更新
4月29日 - ** 辉瑞PFE.N股价上涨4.4%，至24.06美元
** 如果涨势保持，该股将创下近4个月来最大单日涨幅
** 根据伦敦证券交易所集团（LSEG）的数据，辉瑞制药（(link)）第一季度每股收益为0.92美元，超过分析师预期的0.67美元。
** 由于 Paxlovid COVID-19 疗法销售额下降，PFE 第一季度营收不及预期，但该公司仍 坚持610 亿至 640 亿美元的财年营收预期。
** 该公司称，通过削减生产和研究业务成本，将节省 17 亿美元。
** 包括本交易日的走势在内，PFE 在今年已累计下跌约10
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.